https://m2.mtmt.hu/ hun 2026-07-26 01:43 JournalArticle 33298915 VALIDATED true Export Date: 4 January 2023 CODEN: PHTHD Correspondence Address: Zádori, Z.S.; Department of Pharmacology and Pharmacotherapy, Nagyvárad tér 4., Hungary; email: zadori.zoltan@med.semmelweis-univ.hu 0 false 2026-07-20T11:21:56.249+0000 2022-12-20T10:53:35.879+0000 2022-12-08T18:34:21.169+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Tichy Rita (SE_KK_Admin5_TR, admin) true 10026589 2026-07-20T11:18:01.643+0000 2022-12-14T17:40:52.186+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Tichy Rita (SE_KK_Admin5_TR, admin) true 10026589 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Összefoglaló cikk (Folyóiratcikk) 102 true 1134514 true 1 /api/category/1 Category Tudományos true 1 Zádori, Zoltán S. true true /api/journal/3624 REVIEWED PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X true false 3624 false 3624 true 0163-7258 1879-016X Journal FOREIGN 241 108327 108327 29 2023 Funding 2021464 /api/funding/2021464 (FK 138842) false true Funding 2021465 /api/funding/2021465 (TKP2021-EGA-25) false true true 2022 true true true false true false NONE 2026-07-20 false 89 0 82 80 4 82 77 71 60 71 71 69 69 87 2 0 89 87 82 80 0 10 10 Folyóiratcikk Journal Article 24 81 Könyvrészlet Chapter in Book 25 1 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 2 Egyéb Miscellaneous 29 5 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2023 0 11 10 11 10 2024 0 25 24 25 24 2025 0 39 39 39 39 2026 0 14 14 14 14 D1 false 10017488,10015480 false false false 2022-12-13T17:40:51.557+0000 Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 4 8 1 4 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 104611543 /api/authorship/104611543 Zádori, Zoltán S. ✉ [Zádori, Zoltán Sándor (Farmakológia, gas...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 1 0.25 true false true Author 10017488 /api/author/10017488 Zádori Zoltán Sándor (Farmakológia, gasztrointesztinális farmakológia) Zádori Zoltán Sándor true 10017488 true Zádori Zoltán S. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 104611544 /api/authorship/104611544 Király, Kornél [Király, Kornél P (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 2 0.25 false false false Author 10015480 /api/author/10015480 Király Kornél P (Farmakológia) Király Kornél P true 10015480 true Király Kornél true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 104611545 /api/authorship/104611545 Al-Khrasani, Mahmoud [Al-Khrasani, Mahmoud (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 3 0.25 false false false Author 10015484 /api/author/10015484 Al-Khrasani Mahmoud (Farmakológia) Al-Khrasani Mahmoud true 10015484 true Al-Khrasani Mahmoud true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 104611546 /api/authorship/104611546 Gyires, Klára [Gyires, Klára (Farmakológia, gas...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 4 0.25 false true false Author 10007320 /api/author/10007320 Gyires Klára (Farmakológia, gasztrointesztinális farmakológia) Gyires Klára true 10007320 true Gyires Klára true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 22210995 /api/publicationidentifier/22210995 DOI: 10.1016/j.pharmthera.2022.108327 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.pharmthera.2022.108327 https://doi.org/10.1016/j.pharmthera.2022.108327 false true PublicationIdentifier 22999556 /api/publicationidentifier/22999556 WoS: 000906912700005 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000906912700005 https://www.webofscience.com/wos/woscc/full-record/000906912700005 false true PublicationIdentifier 22425488 /api/publicationidentifier/22425488 Scopus: 85143829907 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85143829907 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85143829907 true true PublicationIdentifier 22210996 /api/publicationidentifier/22210996 PubMed: 36473615 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 36473615 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36473615&dopt=Abstract false true SjrRating 11406445 /api/sjrrating/11406445 sjr:D1 (2023) Scopus - Pharmacology (medical) PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X 2 0.0 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2736 /api/classificationexternal/2736 Scopus - Pharmacology (medical) true 2736 true D1 DIRECT true true Reference 36484722 /api/reference/36484722 1. Abdollahi-Roodsaz 2008: Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis., The Journal of Clinical Investigation, 118, p. 205, DOI: 10.1172/JCI32639 1 10.1172/JCI32639 false true Reference 36484723 /api/reference/36484723 2. Abel 1995: Tramadol: an alternative analgesic to traditional opioids and NSAIDs., Journal of Pharmaceutical Care in Pain & Symptom Control, 3, p. 5, DOI: 10.1300/J088v03n01_02 2 10.1300/J088v03n01_02 false true Reference 36484724 /api/reference/36484724 3. Abu 2021: Brief hydromorphone exposure during pregnancy sufficient to induce maternal and neonatal microbial dysbiosis., Journal of Neuroimmune Pharmacology, DOI: 10.1007/s11481-021-10019-2 3 10.1007/s11481-021-10019-2 false true Reference 36484725 /api/reference/36484725 4. Acharya 2017: Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis., Alimentary Pharmacology & Therapeutics, 45, p. 319, DOI: 10.1111/apt.13858 4 10.1111/apt.13858 false true Reference 36484726 /api/reference/36484726 5. Aggarwal 2017: Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration., Clinical and Experimental Immunology, 187, p. 480, DOI: 10.1111/cei.12900 5 10.1111/cei.12900 false true Reference 36484727 /api/reference/36484727 6. Aherne 1979: Serum morphine concentration after oral administration of diamorphine hydrochloride and morphine sulphate., British Journal of Clinical Pharmacology, 8, p. 577, DOI: 10.1111/j.1365-2125.1979.tb01047.x 6 10.1111/j.1365-2125.1979.tb01047.x false true Reference 36484728 /api/reference/36484728 7. Ait-Belgnaoui 2006: Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction., Gut, 55, p. 1090, DOI: 10.1136/gut.2005.084194 7 10.1136/gut.2005.084194 false true Reference 36484729 /api/reference/36484729 8. Akbarali 2019: Gastrointestinal motility, dysbiosis and opioid-induced tolerance: is there a link?., Nature Reviews. Gastroenterology & Hepatology, 16, p. 323, DOI: 10.1038/s41575-019-0150-x 8 10.1038/s41575-019-0150-x false true Reference 36484730 /api/reference/36484730 9. Aletaha 2018: Diagnosis and management of rheumatoid arthritis: a review., JAMA, 320, p. 1360, DOI: 10.1001/jama.2018.13103 9 10.1001/jama.2018.13103 false true Reference 36484731 /api/reference/36484731 10. Al-Janabi 2010: In vitro antibacterial activity of Ibuprofen and acetaminophen., Journal of Global Infectious Diseases, 2, p. 105, DOI: 10.4103/0974-777X.62880 10 10.4103/0974-777X.62880 false true Reference 36484732 /api/reference/36484732 11. Alkanani 2015: Alterations in intestinal microbiota correlate with susceptibility to Type 1 diabetes., Diabetes, 64, p. 3510, DOI: 10.2337/db14-1847 11 10.2337/db14-1847 false true Reference 36484733 /api/reference/36484733 12. Alpizar-Rodriguez 2019: Prevotella copri in individuals at risk for rheumatoid arthritis., Annals of the Rheumatic Diseases, 78, p. 590, DOI: 10.1136/annrheumdis-2018-214514 12 10.1136/annrheumdis-2018-214514 false true Reference 36484734 /api/reference/36484734 13. Annadurai 2002: Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium., Journal of Chemotherapy, 14, p. 47, DOI: 10.1179/joc.2002.14.1.47 13 10.1179/joc.2002.14.1.47 false true Reference 36484735 /api/reference/36484735 14. Arora 2021: Microbial regulation of enteroendocrine cells., Medicine (N Y), 2, p. 553 14 false true Reference 36484736 /api/reference/36484736 15. Asnicar 2021: Blue poo: impact of gut transit time on the gut microbiome using a novel marker., Gut, 70, p. 1665, DOI: 10.1136/gutjnl-2020-323877 15 10.1136/gutjnl-2020-323877 false true Reference 36484737 /api/reference/36484737 16. Asquith 2016: Perturbed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis., Arthritis & Rhematology, 68, p. 2151, DOI: 10.1002/art.39681 16 10.1002/art.39681 false true Reference 36484738 /api/reference/36484738 17. Balogh 2019: Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats., Frontiers in Pharmacology, 10, p. 347, DOI: 10.3389/fphar.2019.00347 17 10.3389/fphar.2019.00347 false true Reference 36484739 /api/reference/36484739 18. Banerjee 2016: Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation., Mucosal Immunology, 9, p. 1418, DOI: 10.1038/mi.2016.9 18 10.1038/mi.2016.9 false true Reference 36484740 /api/reference/36484740 19. Barbara 2005: Interactions between commensal bacteria and gut sensorimotor function in health and disease., The American Journal of Gastroenterology, 100, p. 2560, DOI: 10.1111/j.1572-0241.2005.00230.x 19 10.1111/j.1572-0241.2005.00230.x false true Reference 36484741 /api/reference/36484741 20. Barengolts 2018: Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease., PLoS One, 13, DOI: 10.1371/journal.pone.0194171 20 10.1371/journal.pone.0194171 false true Reference 36484742 /api/reference/36484742 21. Begley 2005: The interaction between bacteria and bile., FEMS Microbiology Reviews, 29, p. 625, DOI: 10.1016/j.femsre.2004.09.003 21 10.1016/j.femsre.2004.09.003 false true Reference 36484743 /api/reference/36484743 22. Bennett 1976: Inhibition of peristalsis in guinea-pig isolated ileum and colon by drugs that block prostaglandin synthesis., British Journal of Pharmacology, 57, p. 335, DOI: 10.1111/j.1476-5381.1976.tb07671.x 22 10.1111/j.1476-5381.1976.tb07671.x false true Reference 36484744 /api/reference/36484744 23. Bergasa 1999: The opioid peptide analog D-Ala2-Met-enkephalinamide decreases bile flow by a central mechanism., Peptides, 20, p. 979, DOI: 10.1016/S0196-9781(99)00091-1 23 10.1016/S0196-9781(99)00091-1 false true Reference 36484745 /api/reference/36484745 24. Bhute 2017: Gut microbial diversity assessment of Indian Type-2-diabetics reveals alterations in eubacteria, archaea, and eukaryotes., Frontiers in Microbiology, 8, p. 214, DOI: 10.3389/fmicb.2017.00214 24 10.3389/fmicb.2017.00214 false true Reference 36484746 /api/reference/36484746 25. Bishop 1960: The bacterial flora of the stomach and small intestine in children with intestinal obstruction., Archives of Disease in Childhood, 35, p. 487, DOI: 10.1136/adc.35.183.487 25 10.1136/adc.35.183.487 false true Reference 36484747 /api/reference/36484747 26. Bjarnason 2018: Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs., Gastroenterology, 154, p. 500, DOI: 10.1053/j.gastro.2017.10.049 26 10.1053/j.gastro.2017.10.049 false true Reference 36484748 /api/reference/36484748 27. Bjarnason 1984: Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs., Lancet, 2, p. 1171, DOI: 10.1016/S0140-6736(84)92739-9 27 10.1016/S0140-6736(84)92739-9 false true Reference 36484749 /api/reference/36484749 28. Blackler 2015: Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID., American Journal of Physiology. Gastrointestinal and Liver Physiology, 308, p. G994, DOI: 10.1152/ajpgi.00066.2015 28 10.1152/ajpgi.00066.2015 false true Reference 36484750 /api/reference/36484750 29. Bokulich 2016: Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study., Clinical Microbiology and Infection, 22, p. 464, DOI: 10.1016/j.cmi.2016.01.013 29 10.1016/j.cmi.2016.01.013 false true Reference 36484751 /api/reference/36484751 30. Bonomo 2020: Fecal transplantation and butyrate improve neuropathic pain, modify immune cell profile, and gene expression in the PNS of obese mice., Proceedings of the National Academy of Sciences of the United States of America, 117, p. 26482, DOI: 10.1073/pnas.2006065117 30 10.1073/pnas.2006065117 false true Reference 36484752 /api/reference/36484752 31. Breban 2017: Faecal microbiota study reveals specific dysbiosis in spondyloarthritis., Annals of the Rheumatic Diseases, 76, p. 1614, DOI: 10.1136/annrheumdis-2016-211064 31 10.1136/annrheumdis-2016-211064 false true Reference 36484753 /api/reference/36484753 32. Brennan 2021: Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum., mBio, p. 12 32 false true Reference 36484754 /api/reference/36484754 33. Brodie 1970: Indomethacin-induced intestinal lesions in the rat., Toxicology and Applied Pharmacology, 17, p. 615, DOI: 10.1016/0041-008X(70)90036-0 33 10.1016/0041-008X(70)90036-0 false true Reference 36484755 /api/reference/36484755 34. Brophy 2008: Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathy., BMC Musculoskeletal Disorders, 9, p. 4, DOI: 10.1186/1471-2474-9-4 34 10.1186/1471-2474-9-4 false true Reference 36484756 /api/reference/36484756 35. Bruch 1978: The role of prostaglandines in peristalsis of the human colon., Acta Hepatogastroenterol (Stuttg), 25, p. 303 35 false true Reference 36484757 /api/reference/36484757 36. Cai 2018: Fecal microbiota transplantation relieve painful diabetic neuropathy: A case report., Medicine (Baltimore), 97, DOI: 10.1097/MD.0000000000013543 36 10.1097/MD.0000000000013543 false true Reference 36484758 /api/reference/36484758 37. Canfora 2019: Gut microbial metabolites in obesity, NAFLD and T2DM., Nature Reviews. Endocrinology, 15, p. 261, DOI: 10.1038/s41574-019-0156-z 37 10.1038/s41574-019-0156-z false true Reference 36484759 /api/reference/36484759 38. Cannarella 2021: Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative/nitrosative profile in people with rheumatoid arthritis., Nutrition, 89, DOI: 10.1016/j.nut.2021.111282 38 10.1016/j.nut.2021.111282 false true Reference 36484760 /api/reference/36484760 39. Cao 2017: Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine., Scientific Reports, 7, p. 10322, DOI: 10.1038/s41598-017-10835-8 39 10.1038/s41598-017-10835-8 false true Reference 36484761 /api/reference/36484761 40. Carbo 2018: Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-alpha inhibitors., PLoS One, 13, DOI: 10.1371/journal.pone.0196281 40 10.1371/journal.pone.0196281 false true Reference 36484762 /api/reference/36484762 41. Cardoneanu 2021: Characteristics of the intestinal microbiome in ankylosing spondylitis., Experimental and Therapeutic Medicine, 22, p. 676, DOI: 10.3892/etm.2021.10108 41 10.3892/etm.2021.10108 false true Reference 36484763 /api/reference/36484763 42. Carroll 2012: Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome., Neurogastroenterology and Motility, 24 42 false true Reference 36484764 /api/reference/36484764 43. Caselli 1989: Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis., Digestion, 44, p. 101, DOI: 10.1159/000199898 43 10.1159/000199898 false true Reference 36484765 /api/reference/36484765 44. Cenit 2017: Influence of gut microbiota on neuropsychiatric disorders., World Journal of Gastroenterology, 23, p. 5486, DOI: 10.3748/wjg.v23.i30.5486 44 10.3748/wjg.v23.i30.5486 false true Reference 36484766 /api/reference/36484766 45. Chan 2017: Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus., Journal of Global Antimicrobial Resistance, 10, p. 70, DOI: 10.1016/j.jgar.2017.03.012 45 10.1016/j.jgar.2017.03.012 false true Reference 36484767 /api/reference/36484767 46. Chan 2010: Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial., Lancet, 376, p. 173, DOI: 10.1016/S0140-6736(10)60673-3 46 10.1016/S0140-6736(10)60673-3 false true Reference 36484768 /api/reference/36484768 47. Chang 2007: Risk factors for chronic constipation and a possible role of analgesics., Neurogastroenterology and Motility, 19, p. 905, DOI: 10.1111/j.1365-2982.2007.00974.x 47 10.1111/j.1365-2982.2007.00974.x false true Reference 36484769 /api/reference/36484769 48. Chen 2016: An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis., Genome Medicine, 8, p. 43, DOI: 10.1186/s13073-016-0299-7 48 10.1186/s13073-016-0299-7 false true Reference 36484770 /api/reference/36484770 49. Cherny 1996: Opioid analgesics: comparative features and prescribing guidelines., Drugs, 51, p. 713, DOI: 10.2165/00003495-199651050-00002 49 10.2165/00003495-199651050-00002 false true Reference 36484771 /api/reference/36484771 50. Chi 2021: Fecal 16S rRNA gene sequencing analysis of changes in the gut microbiota of rats with low-dose aspirin-related intestinal injury., BioMed Research International, 2021, p. 8848686, DOI: 10.1155/2021/8848686 50 10.1155/2021/8848686 false true Reference 36484772 /api/reference/36484772 51. Chiang 2019: An association of gut microbiota with different phenotypes in chinese patients with rheumatoid arthritis., Journal of Clinical Medicine, 8, DOI: 10.3390/jcm8111770 51 10.3390/jcm8111770 false true Reference 36484773 /api/reference/36484773 52. Chiu 2009: Pharmacological exploitation of an off-target antibacterial effect of the cyclooxygenase-2 inhibitor celecoxib against Francisella tularensis., Antimicrobial Agents and Chemotherapy, 53, p. 2998, DOI: 10.1128/AAC.00048-09 52 10.1128/AAC.00048-09 false true Reference 36484774 /api/reference/36484774 53. Colloca 2017: Neuropathic pain., Nature Reviews. Disease Primers, 3, p. 17002, DOI: 10.1038/nrdp.2017.2 53 10.1038/nrdp.2017.2 false true Reference 36484775 /api/reference/36484775 54. Colpaert 2001: Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model., Alimentary Pharmacology & Therapeutics, 15, p. 1827, DOI: 10.1046/j.1365-2036.2001.01111.x 54 10.1046/j.1365-2036.2001.01111.x false true Reference 36484776 /api/reference/36484776 55. Colucci 2018: Pathophysiology of NSAID-associated intestinal lesions in the rat: luminal bacteria and mucosal inflammation as targets for prevention., Frontiers in Pharmacology, 9, p. 1340, DOI: 10.3389/fphar.2018.01340 55 10.3389/fphar.2018.01340 false true Reference 36484777 /api/reference/36484777 56. Costello 2015: Brief report: intestinal dysbiosis in ankylosing spondylitis., Arthritis & Rhematology, 67, p. 686, DOI: 10.1002/art.38967 56 10.1002/art.38967 false true Reference 36484778 /api/reference/36484778 57. Couturier-Maillard 2013: NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer., The Journal of Clinical Investigation, 123, p. 700 57 false true Reference 36484779 /api/reference/36484779 58. Craven 2012: Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease., PLoS One, 7, DOI: 10.1371/journal.pone.0041594 58 10.1371/journal.pone.0041594 false true Reference 36484780 /api/reference/36484780 59. Cristea 2019: Usefulness of complex bacteriological and serological analysis in patients with spondyloarthritis., Experimental and Therapeutic Medicine, 17, p. 3465 59 false true Reference 36484781 /api/reference/36484781 60. Cruz-Lebron 2021: Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity., Gut Microbes, 13, p. 1946368, DOI: 10.1080/19490976.2021.1946368 60 10.1080/19490976.2021.1946368 false true Reference 36484782 /api/reference/36484782 61. Dalby 2006: Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota., Applied and Environmental Microbiology, 72, p. 6707, DOI: 10.1128/AEM.00378-06 61 10.1128/AEM.00378-06 false true Reference 36484783 /api/reference/36484783 62. Darfeuille-Michaud 2004: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease., Gastroenterology, 127, p. 412, DOI: 10.1053/j.gastro.2004.04.061 62 10.1053/j.gastro.2004.04.061 false true Reference 36484784 /api/reference/36484784 63. Dastidar 2000: The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis., International Journal of Antimicrobial Agents, 14, p. 249, DOI: 10.1016/S0924-8579(99)00159-4 63 10.1016/S0924-8579(99)00159-4 false true Reference 36484785 /api/reference/36484785 64. De Vos 1996: Long-term evolution of gut inflammation in patients with spondyloarthropathy., Gastroenterology, 110, p. 1696, DOI: 10.1053/gast.1996.v110.pm8964393 64 10.1053/gast.1996.v110.pm8964393 false true Reference 36484786 /api/reference/36484786 65. Dearlove 1992: The effect of non-steroidal anti-inflammatory drugs on faecal flora and bacterial antibody levels in rheumatoid arthritis., British Journal of Rheumatology, 31, p. 443, DOI: 10.1093/rheumatology/31.7.443 65 10.1093/rheumatology/31.7.443 false true Reference 36484787 /api/reference/36484787 66. Defaye 2020: Microbiota: a novel regulator of pain., Journal of Neural Transmission (Vienna), 127, p. 445, DOI: 10.1007/s00702-019-02083-z 66 10.1007/s00702-019-02083-z false true Reference 36484788 /api/reference/36484788 67. Deng 2018: Manipulation of intestinal dysbiosis by a bacterial mixture ameliorates loperamide-induced constipation in rats., Beneficial Microbes, 9, p. 453, DOI: 10.3920/BM2017.0062 67 10.3920/BM2017.0062 false true Reference 36484789 /api/reference/36484789 68. Deng 2021: The different effects of Chinese Herb Solid Drink and lactulose on gut microbiota in rats with slow transit constipation induced by compound diphenoxylate., Food Research International, 143, DOI: 10.1016/j.foodres.2021.110273 68 10.1016/j.foodres.2021.110273 false true Reference 36484790 /api/reference/36484790 69. Devkota 2012: Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice., Nature, 487, p. 104, DOI: 10.1038/nature11225 69 10.1038/nature11225 false true Reference 36484791 /api/reference/36484791 70. Dighe 2009: Continuous morphine produces more tolerance than intermittent or acute treatment., Pharmacology, Biochemistry, and Behavior, 92, p. 537, DOI: 10.1016/j.pbb.2009.02.004 70 10.1016/j.pbb.2009.02.004 false true Reference 36484792 /api/reference/36484792 71. Dikopoulos 2007: Bile synthesis in rat models of inflammatory bowel diseases., European Journal of Clinical Investigation, 37, p. 222, DOI: 10.1111/j.1365-2362.2007.01779.x 71 10.1111/j.1365-2362.2007.01779.x false true Reference 36484793 /api/reference/36484793 72. Dingle 1999: The effects of NSAID on the matrix of human articular cartilages., Zeitschrift für Rheumatologie, 58, p. 125, DOI: 10.1007/s003930050161 72 10.1007/s003930050161 false true Reference 36484794 /api/reference/36484794 73. Domenico 1989: Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate., Infection and Immunity, 57, p. 3778, DOI: 10.1128/iai.57.12.3778-3782.1989 73 10.1128/iai.57.12.3778-3782.1989 false true Reference 36484795 /api/reference/36484795 74. Donaldson 2016: Gut biogeography of the bacterial microbiota., Nature Reviews. Microbiology, 14, p. 20, DOI: 10.1038/nrmicro3552 74 10.1038/nrmicro3552 false true Reference 36484796 /api/reference/36484796 75. Drago 2002: Effects of subinhibitory concentrations of ibuprofen isobuthanolammonium on virulence factors of uropathogenic Escherichia coli., Journal of Chemotherapy, 14, p. 314, DOI: 10.1179/joc.2002.14.3.314 75 10.1179/joc.2002.14.3.314 false true Reference 36484797 /api/reference/36484797 76. Duboc 2012: Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome., Neurogastroenterology and Motility, 24, p. e246 76 false true Reference 36484798 /api/reference/36484798 77. Duboc 2013: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases., Gut, 62, p. 531, DOI: 10.1136/gutjnl-2012-302578 77 10.1136/gutjnl-2012-302578 false true Reference 36484799 /api/reference/36484799 78. Duncan 2009: The role of pH in determining the species composition of the human colonic microbiota., Environmental Microbiology, 11, p. 2112, DOI: 10.1111/j.1462-2920.2009.01931.x 78 10.1111/j.1462-2920.2009.01931.x false true Reference 36484800 /api/reference/36484800 79. Dutta 2007: Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium., International Journal of Antimicrobial Agents, 30, p. 242, DOI: 10.1016/j.ijantimicag.2007.04.018 79 10.1016/j.ijantimicag.2007.04.018 false true Reference 36484801 /api/reference/36484801 80. Edogawa 2018: Sex differences in NSAID-induced perturbation of human intestinal barrier function and microbiota., The FASEB Journal, fj201800560R 80 false true Reference 36484802 /api/reference/36484802 81. Eerola 1994: Intestinal flora in early rheumatoid arthritis., British Journal of Rheumatology, 33, p. 1030, DOI: 10.1093/rheumatology/33.11.1030 81 10.1093/rheumatology/33.11.1030 false true Reference 36484803 /api/reference/36484803 82. Elinav 2011: NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis., Cell, 145, p. 745, DOI: 10.1016/j.cell.2011.04.022 82 10.1016/j.cell.2011.04.022 false true Reference 36484804 /api/reference/36484804 83. Elliott 1998: Bacteria rapidly colonize and modulate healing of gastric ulcers in rats., The American Journal of Physiology, 275, p. G425 83 false true Reference 36484805 /api/reference/36484805 84. Evans 1988: Measurement of gastrointestinal pH profiles in normal ambulant human subjects., Gut, 29, p. 1035, DOI: 10.1136/gut.29.8.1035 84 10.1136/gut.29.8.1035 false true Reference 36484806 /api/reference/36484806 85. Eyssen 1999: Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora., Applied and Environmental Microbiology, 65, p. 3158, DOI: 10.1128/AEM.65.7.3158-3163.1999 85 10.1128/AEM.65.7.3158-3163.1999 false true Reference 36484807 /api/reference/36484807 86. Fallingborg 1989: pH-profile and regional transit times of the normal gut measured by a radiotelemetry device., Alimentary Pharmacology & Therapeutics, 3, p. 605, DOI: 10.1111/j.1365-2036.1989.tb00254.x 86 10.1111/j.1365-2036.1989.tb00254.x false true Reference 36484808 /api/reference/36484808 87. Feldman 2019: Diabetic neuropathy., Nature Reviews. Disease Primers, 5, p. 41, DOI: 10.1038/s41572-019-0092-1 87 10.1038/s41572-019-0092-1 false true Reference 36484809 /api/reference/36484809 88. Ferro 2021: Probiotic supplementation for rheumatoid arthritis: A promising adjuvant therapy in the gut microbiome era., Frontiers in Pharmacology, 12, DOI: 10.3389/fphar.2021.711788 88 10.3389/fphar.2021.711788 false true Reference 36484810 /api/reference/36484810 89. Finnerup 2015: Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis., Lancet Neurology, 14, p. 162, DOI: 10.1016/S1474-4422(14)70251-0 89 10.1016/S1474-4422(14)70251-0 false true Reference 36484811 /api/reference/36484811 90. Firestein 2017: Immunopathogenesis of Rheumatoid Arthritis., Immunity, 46, p. 183, DOI: 10.1016/j.immuni.2017.02.006 90 10.1016/j.immuni.2017.02.006 false true Reference 36484812 /api/reference/36484812 91. Flint 2012: The role of the gut microbiota in nutrition and health., Nature Reviews. Gastroenterology & Hepatology, 9, p. 577, DOI: 10.1038/nrgastro.2012.156 91 10.1038/nrgastro.2012.156 false true Reference 36484813 /api/reference/36484813 92. Forbes 2018: A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?., Microbiome, 6, p. 221, DOI: 10.1186/s40168-018-0603-4 92 10.1186/s40168-018-0603-4 false true Reference 36484814 /api/reference/36484814 93. Fornai 2014: The Journal of Pharmacology and Experimental Therapeutics, 348, p. 86, DOI: 10.1124/jpet.113.207118 93 10.1124/jpet.113.207118 false true Reference 36484815 /api/reference/36484815 94. Forslund 2015: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota., Nature, 528, p. 262, DOI: 10.1038/nature15766 94 10.1038/nature15766 false true Reference 36484816 /api/reference/36484816 95. Ganesh 2013: Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice., PLoS One, 8, DOI: 10.1371/journal.pone.0074963 95 10.1371/journal.pone.0074963 false true Reference 36484817 /api/reference/36484817 96. García-Valle 2022: Construct validity of the routine assessment of patient index data 3 (RAPID3) in the evaluation of axial spondyloarthritis., The Journal of Rheumatology, 49, p. 36, DOI: 10.3899/jrheum.201362 96 10.3899/jrheum.201362 false true Reference 36484818 /api/reference/36484818 97. Garrett 2007: Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system., Cell, 131, p. 33, DOI: 10.1016/j.cell.2007.08.017 97 10.1016/j.cell.2007.08.017 false true Reference 36484819 /api/reference/36484819 98. Garsin 2010: Ethanolamine utilization in bacterial pathogens: roles and regulation., Nature Reviews. Microbiology, 8, p. 290, DOI: 10.1038/nrmicro2334 98 10.1038/nrmicro2334 false true Reference 36484820 /api/reference/36484820 99. Geirnaert 2017: Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity., Scientific Reports, 7, p. 11450, DOI: 10.1038/s41598-017-11734-8 99 10.1038/s41598-017-11734-8 false true Reference 36484821 /api/reference/36484821 100. Gicquelais 2020: Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment., Scientific Reports, 10, p. 19471, DOI: 10.1038/s41598-020-76570-9 100 10.1038/s41598-020-76570-9 false true Reference 36484822 /api/reference/36484822 101. Gill 2018: Effects of HLA-B27 on gut microbiota in experimental spondyloarthritis implicate an ecological model of dysbiosis., Arthritis & Rhematology, 70, p. 555, DOI: 10.1002/art.40405 101 10.1002/art.40405 false true Reference 36484823 /api/reference/36484823 102. Glowacka 2022: Microbiome profile and molecular pathways alterations in gastrointestinal tract by hydrogen sulfide-releasing nonsteroidal anti-inflammatory drug (ATB-352): Insight into possible safer polypharmacy., Antioxidants & Redox Signaling, 36, p. 189, DOI: 10.1089/ars.2020.8240 102 10.1089/ars.2020.8240 false true Reference 36484824 /api/reference/36484824 103. Gorbach 1969: Bacteria, bile, and the small bowel., Gut, 10, p. 963, DOI: 10.1136/gut.10.12.963 103 10.1136/gut.10.12.963 false true Reference 36484825 /api/reference/36484825 104. Gorkiewicz 2018: Gut microbiome: a new player in gastrointestinal disease., Virchows Archiv, 472, p. 159, DOI: 10.1007/s00428-017-2277-x 104 10.1007/s00428-017-2277-x false true Reference 36484826 /api/reference/36484826 105. Gracey 2020: Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis., Nature Reviews Rheumatology, 16, p. 415, DOI: 10.1038/s41584-020-0454-9 105 10.1038/s41584-020-0454-9 false true Reference 36484827 /api/reference/36484827 106. Grecco 2021: Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: A preliminary analysis., Drug and Alcohol Dependence, 227, DOI: 10.1016/j.drugalcdep.2021.108914 106 10.1016/j.drugalcdep.2021.108914 false true Reference 36484828 /api/reference/36484828 107. Gu 2013: Bacterial community mapping of the mouse gastrointestinal tract., PLoS One, 8, DOI: 10.1371/journal.pone.0074957 107 10.1371/journal.pone.0074957 false true Reference 36484829 /api/reference/36484829 108. Guinane 2013: Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ., Therapeutic Advances in Gastroenterology, 6, p. 295, DOI: 10.1177/1756283X13482996 108 10.1177/1756283X13482996 false true Reference 36484830 /api/reference/36484830 109. Gupta 2016: Fecal microbiota transplantation: in perspective., Therapeutic Advances in Gastroenterology, 9, p. 229, DOI: 10.1177/1756283X15607414 109 10.1177/1756283X15607414 false true Reference 36484831 /api/reference/36484831 110. Hagiwara 2004: Role of unbalanced growth of gram-negative bacteria in ileal ulcer formation in rats treated with a nonsteroidal anti-inflammatory drug., The Journal of Medical Investigation, 51, p. 43, DOI: 10.2152/jmi.51.43 110 10.2152/jmi.51.43 false true Reference 36484832 /api/reference/36484832 111. Hakansson 2015: Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice., Clinical and Experimental Medicine, 15, p. 107, DOI: 10.1007/s10238-013-0270-5 111 10.1007/s10238-013-0270-5 false true Reference 36484833 /api/reference/36484833 112. Hakimian 2019: Dietary supplementation with Omega-3 polyunsaturated fatty acids reduces opioid-seeking behaviors and alters the gut microbiome., Nutrients, 11, DOI: 10.3390/nu11081900 112 10.3390/nu11081900 false true Reference 36484834 /api/reference/36484834 113. Hatakka 2003: Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study., Scandinavian Journal of Rheumatology, 32, p. 211, DOI: 10.1080/03009740310003695 113 10.1080/03009740310003695 false true Reference 36484835 /api/reference/36484835 114. He 2022: Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis., Science Advances, 8, p. eabm1511, DOI: 10.1126/sciadv.abm1511 114 10.1126/sciadv.abm1511 false true Reference 36484836 /api/reference/36484836 115. van der Heijde 2017: 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis., Annals of the Rheumatic Diseases, 76, p. 978, DOI: 10.1136/annrheumdis-2016-210770 115 10.1136/annrheumdis-2016-210770 false true Reference 36484837 /api/reference/36484837 116. van der Heijden 2000: Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides., Arthritis and Rheumatism, 43, p. 593, DOI: 10.1002/1529-0131(200003)43:3&lt;593::AID-ANR16&gt;3.0.CO;2-1 116 10.1002/1529-0131(200003)43:3&lt;593::AID-ANR16&gt;3.0.CO;2-1 false true Reference 36484838 /api/reference/36484838 117. Hill 2014: Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic., Nature Reviews. Gastroenterology & Hepatology, 11, p. 506, DOI: 10.1038/nrgastro.2014.66 117 10.1038/nrgastro.2014.66 false true Reference 36484839 /api/reference/36484839 118. Hofmann 1999: The continuing importance of bile acids in liver and intestinal disease., Archives of Internal Medicine, 159, p. 2647, DOI: 10.1001/archinte.159.22.2647 118 10.1001/archinte.159.22.2647 false true Reference 36484840 /api/reference/36484840 119. Holzer 2008: New approaches to the treatment of opioid-induced constipation., European Review for Medical and Pharmacological Sciences, 12, p. 119 119 false true Reference 36484841 /api/reference/36484841 120. Hutka 2021: The nonsteroidal anti-inflammatory drug ketorolac alters the small intestinal microbiota and bile acids without inducing intestinal damage or delaying peristalsis in the rat., Frontiers in Pharmacology, 12, DOI: 10.3389/fphar.2021.664177 120 10.3389/fphar.2021.664177 false true Reference 36484842 /api/reference/36484842 121. Hwang 2017: Genes and gut bacteria involved in luminal butyrate reduction caused by diet and loperamide., Genes (Basel), 8, p. 350, DOI: 10.3390/genes8120350 121 10.3390/genes8120350 false true Reference 36484843 /api/reference/36484843 122. Ibrahim 2021: Characterisation of gut microbiota of obesity and type 2 diabetes in a rodent model., Bioscience of Microbiota Food and Health, 40, p. 65, DOI: 10.12938/bmfh.2019-031 122 10.12938/bmfh.2019-031 false true Reference 36484844 /api/reference/36484844 123. Imaeda 2012: Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice., Digestion, 86, p. 250, DOI: 10.1159/000341508 123 10.1159/000341508 false true Reference 36484845 /api/reference/36484845 124. Inagaki 2006: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor., Proceedings of the National Academy of Sciences of the United States of America, 103, p. 3920, DOI: 10.1073/pnas.0509592103 124 10.1073/pnas.0509592103 false true Reference 36484846 /api/reference/36484846 125. Inatomi 2021: Effects of probiotics on loperamide-induced constipation in rats., Scientific Reports, 11, p. 24098, DOI: 10.1038/s41598-021-02931-7 125 10.1038/s41598-021-02931-7 false true Reference 36484847 /api/reference/36484847 126. Jackson 2018: Gut microbiota associations with common diseases and prescription medications in a population-based cohort., Nature Communications, 9, p. 2655, DOI: 10.1038/s41467-018-05184-7 126 10.1038/s41467-018-05184-7 false true Reference 36484848 /api/reference/36484848 127. Jenks 2010: Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial., The Journal of Rheumatology, 37, p. 2118, DOI: 10.3899/jrheum.100193 127 10.3899/jrheum.100193 false true Reference 36484849 /api/reference/36484849 128. Jeong 2019: Gut microbial composition and function are altered in patients with early rheumatoid arthritis., Journal of Clinical Medicine, 8, DOI: 10.3390/jcm8050693 128 10.3390/jcm8050693 false true Reference 36484850 /api/reference/36484850 129. Jimenez-Serna 2011: Effect of different antibiotics and non-steroidal anti-inflammatory drugs on the growth of Lactobacillus casei Shirota., Current Microbiology, 62, p. 1028, DOI: 10.1007/s00284-010-9819-7 129 10.1007/s00284-010-9819-7 false true Reference 36484851 /api/reference/36484851 130. Johnson 2021: Chronic Opioid Administration is Associated with Prevotella-dominated Dysbiosis in SIVmac251 Infected, cART-treated Macaques., Journal of Neuroimmune Pharmacology, DOI: 10.1007/s11481-021-09993-4 130 10.1007/s11481-021-09993-4 false true Reference 36484852 /api/reference/36484852 131. Jones 1995: Gastrointestinal side-effects of NSAIDs in the community., The British Journal of Clinical Practice, 49, p. 67 131 false true Reference 36484853 /api/reference/36484853 132. Kaakoush 2020: Sutterella species, IgA-degrading bacteria in ulcerative colitis., Trends in Microbiology, 28, p. 519, DOI: 10.1016/j.tim.2020.02.018 132 10.1016/j.tim.2020.02.018 false true Reference 36484854 /api/reference/36484854 133. Kamiya 2006: Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats., Gut, 55, p. 191, DOI: 10.1136/gut.2005.070987 133 10.1136/gut.2005.070987 false true Reference 36484855 /api/reference/36484855 134. Kang 2017: The effect of gut microbiome on tolerance to morphine mediated antinociception in mice., Scientific Reports, 7, p. 42658, DOI: 10.1038/srep42658 134 10.1038/srep42658 false true Reference 36484856 /api/reference/36484856 135. Karlsson 2013: Gut metagenome in European women with normal, impaired and diabetic glucose control., Nature, 498, p. 99, DOI: 10.1038/nature12198 135 10.1038/nature12198 false true Reference 36484857 /api/reference/36484857 136. Karreman 2017: The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis., Journal of Crohn's & Colitis, 11, p. 631 136 false true Reference 36484858 /api/reference/36484858 137. Kashyap 2013: Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice., Gastroenterology, 144, p. 967, DOI: 10.1053/j.gastro.2013.01.047 137 10.1053/j.gastro.2013.01.047 false true Reference 36484859 /api/reference/36484859 138. Kawashima 2020: Histamine H2-receptor antagonists improve non-steroidal anti-inflammatory drug-induced intestinal dysbiosis., International Journal of Molecular Sciences, 21, DOI: 10.3390/ijms21218166 138 10.3390/ijms21218166 false true Reference 36484860 /api/reference/36484860 139. Kent 1969: Small intestinal ulcers and intestinal flora in rats given indomethacin., The American Journal of Pathology, 54, p. 237 139 false true Reference 36484861 /api/reference/36484861 140. Kent 1968: Intestinal flora in whole-body and intestinal X-irradiated rats - irradiation caused dysbiosis in mid-small intestine and cecum of rats, increase in coliforms, enterococci and proteus., Radiation Research, 35, p. 635, DOI: 10.2307/3572521 140 10.2307/3572521 false true Reference 36484862 /api/reference/36484862 141. Kim 2021: Laxative effects of phlorotannins derived from ecklonia cava on loperamide-induced constipation in SD rats., Molecules, p. 26 141 false true Reference 36484863 /api/reference/36484863 142. Kim 2021: Prebiotics/probiotics mixture induced changes in cecal microbiome and intestinal morphology alleviated the loperamide-induced constipation in rat., Food Science of Animal Resources, 41, p. 527, DOI: 10.5851/kosfa.2021.e17 142 10.5851/kosfa.2021.e17 false true Reference 36484864 /api/reference/36484864 143. Kim 2005: Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria., Gastroenterology, 128, p. 891, DOI: 10.1053/j.gastro.2005.02.009 143 10.1053/j.gastro.2005.02.009 false true Reference 36484865 /api/reference/36484865 144. Kinouchi 1998: Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation., Microbiology and Immunology, 42, p. 347, DOI: 10.1111/j.1348-0421.1998.tb02294.x 144 10.1111/j.1348-0421.1998.tb02294.x false true Reference 36484866 /api/reference/36484866 145. Kishikawa 2020: Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population., Annals of the Rheumatic Diseases, 79, p. 103, DOI: 10.1136/annrheumdis-2019-215743 145 10.1136/annrheumdis-2019-215743 false true Reference 36484867 /api/reference/36484867 146. Klingberg 2019: A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin., Arthritis Research & Therapy, 21, p. 248, DOI: 10.1186/s13075-019-2018-4 146 10.1186/s13075-019-2018-4 false true Reference 36484868 /api/reference/36484868 147. Kohashi 1985: Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats., Microbiology and Immunology, 29, p. 487, DOI: 10.1111/j.1348-0421.1985.tb00851.x 147 10.1111/j.1348-0421.1985.tb00851.x false true Reference 36484869 /api/reference/36484869 148. Kragsnaes 2018: Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial., BMJ Open, 8, DOI: 10.1136/bmjopen-2017-019231 148 10.1136/bmjopen-2017-019231 false true Reference 36484870 /api/reference/36484870 149. Kurata 2015: Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model., Journal of Clinical Biochemistry and Nutrition, 56, p. 20, DOI: 10.3164/jcbn.14-67 149 10.3164/jcbn.14-67 false true Reference 36484871 /api/reference/36484871 150. Lackó 2012: A novel μ-opioid receptor ligand with high in vitro and in vivo agonist efficacy., Current Medicinal Chemistry, 19, p. 4699, DOI: 10.2174/092986712803306376 150 10.2174/092986712803306376 false true Reference 36484872 /api/reference/36484872 151. Laine 2003: Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use., Gastroenterology, 124, p. 288, DOI: 10.1053/gast.2003.50054 151 10.1053/gast.2003.50054 false true Reference 36484873 /api/reference/36484873 152. Laine 2008: Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac., Gastroenterology, 135, p. 1517, DOI: 10.1053/j.gastro.2008.07.067 152 10.1053/j.gastro.2008.07.067 false true Reference 36484874 /api/reference/36484874 153. Lanas 2009: Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications., Gastroenterology Clinics of North America, 38, p. 333, DOI: 10.1016/j.gtc.2009.03.007 153 10.1016/j.gtc.2009.03.007 false true Reference 36484875 /api/reference/36484875 154. Larsen 2010: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults., PLoS One, 5, DOI: 10.1371/journal.pone.0009085 154 10.1371/journal.pone.0009085 false true Reference 36484876 /api/reference/36484876 155. Laudy 2016: The influence of efflux pump inhibitors on the activity of non-antibiotic NSAIDS against gram-negative rods., PLoS One, 11, DOI: 10.1371/journal.pone.0147131 155 10.1371/journal.pone.0147131 false true Reference 36484877 /api/reference/36484877 156. Lázár 2019: Lack of small intestinal dysbiosis following long-term selective inhibition of cyclooxygenase-2 by rofecoxib in the rat., Cells, 8, DOI: 10.3390/cells8030251 156 10.3390/cells8030251 false true Reference 36484878 /api/reference/36484878 157. Lázár 2021: A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine., Biochemical Pharmacology, 190, DOI: 10.1016/j.bcp.2021.114590 157 10.1016/j.bcp.2021.114590 false true Reference 36484879 /api/reference/36484879 158. Le Bastard 2018: Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications., Alimentary Pharmacology & Therapeutics, 47, p. 332, DOI: 10.1111/apt.14451 158 10.1111/apt.14451 false true Reference 36484880 /api/reference/36484880 159. Lee 2018: The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence., Neuropsychopharmacology, 43, p. 2606, DOI: 10.1038/s41386-018-0211-9 159 10.1038/s41386-018-0211-9 false true Reference 36484881 /api/reference/36484881 160. Li 2020: Gut microbiota is involved in the alleviation of loperamide-induced constipation by honey supplementation in mice., Food Science & Nutrition, 8, p. 4388, DOI: 10.1002/fsn3.1736 160 10.1002/fsn3.1736 false true Reference 36484882 /api/reference/36484882 161. Liang 2015: Bidirectional interactions between indomethacin and the murine intestinal microbiota., Elife, 4, DOI: 10.7554/eLife.08973 161 10.7554/eLife.08973 false true Reference 36484883 /api/reference/36484883 162. Liang 2022: The anti-constipation effects of raffino-oligosaccharide on gut function in mice using neurotransmitter analyses, 16S rRNA sequencing and targeted screening., Molecules, 27, DOI: 10.3390/molecules27072235 162 10.3390/molecules27072235 false true Reference 36484884 /api/reference/36484884 163. Lichtenberger 2015: Suppression of contractile activity in the small intestine by indomethacin and omeprazole., American Journal of Physiology. Gastrointestinal and Liver Physiology, 308, p. G785, DOI: 10.1152/ajpgi.00458.2014 163 10.1152/ajpgi.00458.2014 false true Reference 36484885 /api/reference/36484885 164. Lin 2020: Gut microbiota regulates neuropathic pain: potential mechanisms and therapeutic strategy., The Journal of Headache and Pain, 21, p. 103, DOI: 10.1186/s10194-020-01170-x 164 10.1186/s10194-020-01170-x false true Reference 36484886 /api/reference/36484886 165. Lin 2014: HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats., PLoS One, 9 165 false true Reference 36484887 /api/reference/36484887 166. Lin 2021: Constipation induced gut microbiota dysbiosis exacerbates experimental autoimmune encephalomyelitis in C57BL/6 mice., Journal of Translational Medicine, 19, p. 317, DOI: 10.1186/s12967-021-02995-z 166 10.1186/s12967-021-02995-z false true Reference 36484888 /api/reference/36484888 167. Liu 2013: Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis., Current Microbiology, 67, p. 170, DOI: 10.1007/s00284-013-0338-1 167 10.1007/s00284-013-0338-1 false true Reference 36484889 /api/reference/36484889 168. Lorenzo-Zuniga 2003: Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats., Hepatology, 37, p. 551, DOI: 10.1053/jhep.2003.50116 168 10.1053/jhep.2003.50116 false true Reference 36484890 /api/reference/36484890 169. Louis 2007: Understanding the effects of diet on bacterial metabolism in the large intestine., Journal of Applied Microbiology, 102, p. 1197, DOI: 10.1111/j.1365-2672.2007.03322.x 169 10.1111/j.1365-2672.2007.03322.x false true Reference 36484891 /api/reference/36484891 170. Lu 2018: Activation of intestinal GR-FXR and PPARalpha-UGT signaling exacerbates ibuprofen-induced enteropathy in mice., Archives of Toxicology, 92, p. 1249, DOI: 10.1007/s00204-017-2139-y 170 10.1007/s00204-017-2139-y false true Reference 36484892 /api/reference/36484892 171. Lupp 2007: Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae., Cell Host & Microbe, 2, p. 204, DOI: 10.1016/j.chom.2007.08.002 171 10.1016/j.chom.2007.08.002 false true Reference 36484893 /api/reference/36484893 172. Maeda 2016: Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine., Arthritis & Rhematology, 68, p. 2646, DOI: 10.1002/art.39783 172 10.1002/art.39783 false true Reference 36484894 /api/reference/36484894 173. Maiden 2007: Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study., Clinical Gastroenterology and Hepatology, 5, p. 1040, DOI: 10.1016/j.cgh.2007.04.031 173 10.1016/j.cgh.2007.04.031 false true Reference 36484895 /api/reference/36484895 174. Maier 2018: Extensive impact of non-antibiotic drugs on human gut bacteria., Nature, 555, p. 623, DOI: 10.1038/nature25979 174 10.1038/nature25979 false true Reference 36484896 /api/reference/36484896 175. Mäkivuokko 2010: The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition., The British Journal of Nutrition, 103, p. 227, DOI: 10.1017/S0007114509991553 175 10.1017/S0007114509991553 false true Reference 36484897 /api/reference/36484897 176. Makizaki 2021: Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis., PLoS One, 16, DOI: 10.1371/journal.pone.0248584 176 10.1371/journal.pone.0248584 false true Reference 36484898 /api/reference/36484898 177. Manasson 2020: The microbiome in rheumatology: Where are we and where should we go?., Annals of the Rheumatic Diseases, 79, p. 727, DOI: 10.1136/annrheumdis-2019-216631 177 10.1136/annrheumdis-2019-216631 false true Reference 36484899 /api/reference/36484899 178. Manasson 2020: Interleukin-17 inhibition in spondyloarthritis is associated with subclinical gut microbiome perturbations and a distinctive Interleukin-25-driven intestinal inflammation., Arthritis & Rhematology, 72, p. 645, DOI: 10.1002/art.41169 178 10.1002/art.41169 false true Reference 36484900 /api/reference/36484900 179. Mandel 2010: Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial., BMC Complementary and Alternative Medicine, 10, p. 1, DOI: 10.1186/1472-6882-10-1 179 10.1186/1472-6882-10-1 false true Reference 36484901 /api/reference/36484901 180. Martínez-Navarro 2019: Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?., European Journal of Pain, 23, p. 435, DOI: 10.1002/ejp.1328 180 10.1002/ejp.1328 false true Reference 36484902 /api/reference/36484902 181. Maseda 2019: Nonsteroidal Anti-inflammatory drugs alter the microbiota and exacerbate clostridium difficile colitis while dysregulating the inflammatory response., mBio, p. 10 181 false true Reference 36484903 /api/reference/36484903 182. Mayo 2016: Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci., Physiological Reports, 4, DOI: 10.14814/phy2.12725 182 10.14814/phy2.12725 false true Reference 36484904 /api/reference/36484904 183. Mazumdar 2006: Diclofenac in the management of E. coli urinary tract infections., In Vivo, 20, p. 613 183 false true Reference 36484905 /api/reference/36484905 184. McConnell 2008: Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments., The Journal of Pharmacy and Pharmacology, 60, p. 63, DOI: 10.1211/jpp.60.1.0008 184 10.1211/jpp.60.1.0008 false true Reference 36484906 /api/reference/36484906 185. McLane 2017: Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal., Life Sciences, 185, p. 1, DOI: 10.1016/j.lfs.2017.07.016 185 10.1016/j.lfs.2017.07.016 false true Reference 36484907 /api/reference/36484907 186. Meng 2015: Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization., Scientific Reports, 5, p. 10918, DOI: 10.1038/srep10918 186 10.1038/srep10918 false true Reference 36484908 /api/reference/36484908 187. Meng 2013: Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner., PLoS One, 8 187 false true Reference 36484909 /api/reference/36484909 188. Mischel 2020: The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance., The Journal of Pain, 21, p. 751, DOI: 10.1016/j.jpain.2019.11.015 188 10.1016/j.jpain.2019.11.015 false true Reference 36484910 /api/reference/36484910 189. Mohammadzadeh 2021: Pharmacological evidence on augmented antiallodynia following systemic Co-Treatment with GlyT-1 and GlyT-2 inhibitors in rat neuropathic pain model., International Journal of Molecular Sciences, 22, DOI: 10.3390/ijms22052479 189 10.3390/ijms22052479 false true Reference 36484911 /api/reference/36484911 190. Monteros 2021: Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug., Scientific Reports, 11, p. 571, DOI: 10.1038/s41598-020-80482-z 190 10.1038/s41598-020-80482-z false true Reference 36484912 /api/reference/36484912 191. Montrose 2016: Celecoxib alters the intestinal microbiota and metabolome in association with reducing polyp burden., Cancer Prevention Research (Philadelphia, Pa.), 9, p. 721, DOI: 10.1158/1940-6207.CAPR-16-0095 191 10.1158/1940-6207.CAPR-16-0095 false true Reference 36484913 /api/reference/36484913 192. Mouton 2018: MIC-based dose adjustment: facts and fables., The Journal of Antimicrobial Chemotherapy, 73, p. 564, DOI: 10.1093/jac/dkx427 192 10.1093/jac/dkx427 false true Reference 36484914 /api/reference/36484914 193. Ng 2009: Mechanisms of action of probiotics: recent advances., Inflammatory Bowel Diseases, 15, p. 300, DOI: 10.1002/ibd.20602 193 10.1002/ibd.20602 false true Reference 36484915 /api/reference/36484915 194. Ng 2022: Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial., Gut, 71, p. 716, DOI: 10.1136/gutjnl-2020-323617 194 10.1136/gutjnl-2020-323617 false true Reference 36484916 /api/reference/36484916 195. Nguyen 2015: How informative is the mouse for human gut microbiota research?., Disease Models & Mechanisms, 8, p. 1, DOI: 10.1242/dmm.017400 195 10.1242/dmm.017400 false true Reference 36484917 /api/reference/36484917 196. O'Brien 2014: Mouse models of diabetic neuropathy., ILAR Journal, 54, p. 259, DOI: 10.1093/ilar/ilt052 196 10.1093/ilar/ilt052 false true Reference 36484918 /api/reference/36484918 197. Oshiro 2022: Associations between intestinal microbiota, fecal properties, and dietary fiber conditions: The Japanese traditional medicine Junchoto ameliorates dietary fiber deficit-induced constipation with F/B ratio alteration in rats., Biomedicine & Pharmacotherapy, 152, DOI: 10.1016/j.biopha.2022.113263 197 10.1016/j.biopha.2022.113263 false true Reference 36484919 /api/reference/36484919 198. O'Sullivan 2019: Single-cell glia and neuron gene expression in the central amygdala in opioid withdrawal suggests inflammation with correlated gut dysbiosis., Frontiers in Neuroscience, 13, p. 665, DOI: 10.3389/fnins.2019.00665 198 10.3389/fnins.2019.00665 false true Reference 36484920 /api/reference/36484920 199. Ott 2004: Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease., Gut, 53, p. 685, DOI: 10.1136/gut.2003.025403 199 10.1136/gut.2003.025403 false true Reference 36484921 /api/reference/36484921 200. Pane 2022: Role of gut microbiota in neuropathy and neuropathic pain states: A systematic preclinical review., Neurobiology of Disease, 170, DOI: 10.1016/j.nbd.2022.105773 200 10.1016/j.nbd.2022.105773 false true Reference 36484922 /api/reference/36484922 201. Pap 2015: Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings., Nature Reviews Rheumatology, 11, p. 606, DOI: 10.1038/nrrheum.2015.95 201 10.1038/nrrheum.2015.95 false true Reference 36484923 /api/reference/36484923 202. Pathan 2012: Basic opioid pharmacology: an update., British Journal of Pain, 6, p. 11, DOI: 10.1177/2049463712438493 202 10.1177/2049463712438493 false true Reference 36484924 /api/reference/36484924 203. Pettigrew 2019: Gastrointestinal microbiota disruption and risk of colonization with carbapenem-resistant pseudomonas aeruginosa in intensive care unit patients., Clinical Infectious Diseases, 69, p. 604, DOI: 10.1093/cid/ciy936 203 10.1093/cid/ciy936 false true Reference 36484925 /api/reference/36484925 204. Pianta 2017: Evidence of the immune relevance of Prevotella Copri, a gut microbe, in patients with rheumatoid arthritis., Arthritis & Rhematology, 69, p. 964, DOI: 10.1002/art.40003 204 10.1002/art.40003 false true Reference 36484926 /api/reference/36484926 205. Picchianti-Diamanti 2018: Analysis of Gut microbiota in rheumatoid arthritis patients: disease-related dysbiosis and modifications induced by etanercept., International Journal of Molecular Sciences, 19, DOI: 10.3390/ijms19102938 205 10.3390/ijms19102938 false true Reference 36484927 /api/reference/36484927 206. Pineda Mde 2011: A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis., Medical Science Monitor, 17 206 false true Reference 36484928 /api/reference/36484928 207. Plein 2018: Opioids and the immune system - friend or foe., British Journal of Pharmacology, 175, p. 2717, DOI: 10.1111/bph.13750 207 10.1111/bph.13750 false true Reference 36484929 /api/reference/36484929 208. Prizment 2020: Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk., Alimentary Pharmacology & Therapeutics, 52, p. 976 208 false true Reference 36484930 /api/reference/36484930 209. Pryde 2002: The microbiology of butyrate formation in the human colon., FEMS Microbiology Letters, 217, p. 133, DOI: 10.1111/j.1574-6968.2002.tb11467.x 209 10.1111/j.1574-6968.2002.tb11467.x false true Reference 36484931 /api/reference/36484931 210. Pushpanathan 2016: Gut Microbiota in Type 2 Diabetes individuals and correlation with monocyte chemoattractant protein1 and interferon gamma from patients attending a tertiary care centre in Chennai, India., Indian Journal of Endocrinology and Metabolism, 20, p. 523, DOI: 10.4103/2230-8210.183474 210 10.4103/2230-8210.183474 false true Reference 36484932 /api/reference/36484932 211. Qin 2012: A metagenome-wide association study of gut microbiota in type 2 diabetes., Nature, 490, p. 55, DOI: 10.1038/nature11450 211 10.1038/nature11450 false true Reference 36484933 /api/reference/36484933 212. Queiro-Silva 2021: Do NSAIDs take us away from treatment goals in axial spondyloarthritis: a story about dysbiosis or just a matter of bias?., Frontirs in Medicine (Lausanne), 8 212 false true Reference 36484934 /api/reference/36484934 213. Rajchgot 2019: Neurons and microglia; a sickly-sweet duo in diabetic pain neuropathy., Frontiers in Neuroscience, 13, p. 25, DOI: 10.3389/fnins.2019.00025 213 10.3389/fnins.2019.00025 false true Reference 36484935 /api/reference/36484935 214. Ramirez 2020: Antibiotics as major disruptors of gut microbiota., Frontiers in Cellular and Infection Microbiology, 10, DOI: 10.3389/fcimb.2020.572912 214 10.3389/fcimb.2020.572912 false true Reference 36484936 /api/reference/36484936 215. Rashid 2007: Ankylosing spondylitis is linked to Klebsiella--the evidence., Clinical Rheumatology, 26, p. 858, DOI: 10.1007/s10067-006-0488-7 215 10.1007/s10067-006-0488-7 false true Reference 36484937 /api/reference/36484937 216. Rath 1996: Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats., The Journal of Clinical Investigation, 98, p. 945, DOI: 10.1172/JCI118878 216 10.1172/JCI118878 false true Reference 36484938 /api/reference/36484938 217. Reagan-Shaw 2008: Dose translation from animal to human studies revisited., The FASEB Journal, 22, p. 659, DOI: 10.1096/fj.07-9574LSF 217 10.1096/fj.07-9574LSF false true Reference 36484939 /api/reference/36484939 218. Rehaume 2019: IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota., Annals of the Rheumatic Diseases, 78, p. 494, DOI: 10.1136/annrheumdis-2018-214381 218 10.1136/annrheumdis-2018-214381 false true Reference 36484940 /api/reference/36484940 219. Ren 2022: Dose- and sex-dependent bidirectional relationship between intravenous fentanyl self-administration and gut microbiota., Microorganisms, 10, DOI: 10.3390/microorganisms10061127 219 10.3390/microorganisms10061127 false true Reference 36484941 /api/reference/36484941 220. Reuter 1997: Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation., Gastroenterology, 112, p. 109, DOI: 10.1016/S0016-5085(97)70225-7 220 10.1016/S0016-5085(97)70225-7 false true Reference 36484942 /api/reference/36484942 221. Reyes-Castillo 2021: Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance., Clinical and Experimental Medicine, 21, p. 1, DOI: 10.1007/s10238-020-00647-y 221 10.1007/s10238-020-00647-y false true Reference 36484943 /api/reference/36484943 222. Ridlon 2016: Consequences of bile salt biotransformations by intestinal bacteria., Gut Microbes, 7, p. 22, DOI: 10.1080/19490976.2015.1127483 222 10.1080/19490976.2015.1127483 false true Reference 36484944 /api/reference/36484944 223. Robert 1977: Resistance of germfree rats to indomethacin-induced intestinal lesions., Prostaglandins, 14, p. 333, DOI: 10.1016/0090-6980(77)90178-2 223 10.1016/0090-6980(77)90178-2 false true Reference 36484945 /api/reference/36484945 224. Roesch 2009: Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model., The ISME Journal, 3, p. 536, DOI: 10.1038/ismej.2009.5 224 10.1038/ismej.2009.5 false true Reference 36484946 /api/reference/36484946 225. Rogers 2016: The influence of non-steroidal anti-inflammatory drugs on the gut microbiome., Clinical Microbiology and Infection, 22, p. 178 e171, DOI: 10.1016/j.cmi.2015.10.003 225 10.1016/j.cmi.2015.10.003 false true Reference 36484947 /api/reference/36484947 226. Rosenbaum 2018: The microbiome and HLA-B27-associated acute anterior uveitis., Nature Reviews Rheumatology, 14, p. 704, DOI: 10.1038/s41584-018-0097-2 226 10.1038/s41584-018-0097-2 false true Reference 36484948 /api/reference/36484948 227. Rosenberg 1985: Antimicrobial activity of bupivacaine and morphine., Anesthesiology, 62, p. 178, DOI: 10.1097/00000542-198502000-00015 227 10.1097/00000542-198502000-00015 false true Reference 36484949 /api/reference/36484949 228. Rousseaux 2007: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors., Nature Medicine, 13, p. 35, DOI: 10.1038/nm1521 228 10.1038/nm1521 false true Reference 36484950 /api/reference/36484950 229. Rudwaleit 2011: The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general., Annals of the Rheumatic Diseases, 70, p. 25, DOI: 10.1136/ard.2010.133645 229 10.1136/ard.2010.133645 false true Reference 36484951 /api/reference/36484951 230. Runkel 1993: Alterations in rat intestinal transit by morphine promote bacterial translocation., Digestive Diseases and Sciences, 38, p. 1530, DOI: 10.1007/BF01308616 230 10.1007/BF01308616 false true Reference 36484952 /api/reference/36484952 231. Salsitz 2016: Chronic pain, chronic opioid addiction: a complex nexus., Journal of Medical Toxicology, 12, p. 54, DOI: 10.1007/s13181-015-0521-9 231 10.1007/s13181-015-0521-9 false true Reference 36484953 /api/reference/36484953 232. Sanges 2009: Probiotics in spondyloarthropathy associated with ulcerative colitis: a pilot study., European Review for Medical and Pharmacological Sciences, 13, p. 233 232 false true Reference 36484954 /api/reference/36484954 233. Sanna 2019: Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases., Nature Genetics, 51, p. 600, DOI: 10.1038/s41588-019-0350-x 233 10.1038/s41588-019-0350-x false true Reference 36484955 /api/reference/36484955 234. Sanyal 1993: Ibuprofen, a unique anti-inflammatory compound with antifungal activity against dermatophytes., Letters in Applied Microbiology, 17, p. 109, DOI: 10.1111/j.1472-765X.1993.tb01436.x 234 10.1111/j.1472-765X.1993.tb01436.x false true Reference 36484956 /api/reference/36484956 235. Satoh 2012: Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility., The Journal of Pharmacology and Experimental Therapeutics, 343, p. 270, DOI: 10.1124/jpet.112.197475 235 10.1124/jpet.112.197475 false true Reference 36484957 /api/reference/36484957 236. Satoh 2014: Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats., The Journal of Pharmacology and Experimental Therapeutics, 348, p. 227, DOI: 10.1124/jpet.113.208991 236 10.1124/jpet.113.208991 false true Reference 36484958 /api/reference/36484958 237. Satoh 2009: Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats., Gut, 58, p. 1590, DOI: 10.1136/gut.2008.156596 237 10.1136/gut.2008.156596 false true Reference 36484959 /api/reference/36484959 238. Sattar 2017: Research digest: the risks of type 2 diabetes at a young age., The Lancet Diabetes & Endocrinology, 5, p. 331, DOI: 10.1016/S2213-8587(17)30117-1 238 10.1016/S2213-8587(17)30117-1 false true Reference 36484960 /api/reference/36484960 239. Scales 2016: A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs., Journal of Leukocyte Biology, 100, p. 943, DOI: 10.1189/jlb.3MR0316-106R 239 10.1189/jlb.3MR0316-106R false true Reference 36484961 /api/reference/36484961 240. Scarpignato 2017: Rifaximin reduces the number and severity of intestinal lesions associated with use of nonsteroidal anti-inflammatory drugs in humans., Gastroenterology, 152, p. 980, DOI: 10.1053/j.gastro.2016.12.007 240 10.1053/j.gastro.2016.12.007 false true Reference 36484962 /api/reference/36484962 241. Schembri 2018: Are opioids effective in relieving neuropathic pain?., SN Comprehensive Clinical Medicine, 1, p. 30, DOI: 10.1007/s42399-018-0009-4 241 10.1007/s42399-018-0009-4 false true Reference 36484963 /api/reference/36484963 242. Scher 2016: The lung microbiota in early rheumatoid arthritis and autoimmunity., Microbiome, 4, p. 60, DOI: 10.1186/s40168-016-0206-x 242 10.1186/s40168-016-0206-x false true Reference 36484964 /api/reference/36484964 243. Scher 2013: Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis., Elife, 2, DOI: 10.7554/eLife.01202 243 10.7554/eLife.01202 false true Reference 36484965 /api/reference/36484965 244. Scher 2015: Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease., Arthritis & Rhematology, 67, p. 128, DOI: 10.1002/art.38892 244 10.1002/art.38892 false true Reference 36484966 /api/reference/36484966 245. Scher 2012: Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis., Arthritis and Rheumatism, 64, p. 3083, DOI: 10.1002/art.34539 245 10.1002/art.34539 false true Reference 36484967 /api/reference/36484967 246. Schreiber 2015: Diabetic neuropathic pain: Physiopathology and treatment., World Journal of Diabetes, 6, p. 432, DOI: 10.4239/wjd.v6.i3.432 246 10.4239/wjd.v6.i3.432 false true Reference 36484968 /api/reference/36484968 247. Schulz 2012: Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics., Critical Care, 16, p. R136, DOI: 10.1186/cc11441 247 10.1186/cc11441 false true Reference 36484969 /api/reference/36484969 248. Sender 2016: Revised estimates for the number of human and bacteria cells in the body., PLoS Biology, 14, DOI: 10.1371/journal.pbio.1002533 248 10.1371/journal.pbio.1002533 false true Reference 36484970 /api/reference/36484970 249. Severijnen 1990: Intestinal flora of patients with rheumatoid arthritis: induction of chronic arthritis in rats by cell wall fragments from isolated Eubacterium aerofaciens strains., British Journal of Rheumatology, 29, p. 433, DOI: 10.1093/rheumatology/29.6.433 249 10.1093/rheumatology/29.6.433 false true Reference 36484971 /api/reference/36484971 250. Shahbazian 2001: Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors., British Journal of Pharmacology, 132, p. 1299, DOI: 10.1038/sj.bjp.0703940 250 10.1038/sj.bjp.0703940 false true Reference 36484972 /api/reference/36484972 251. Sharip 2020: Understanding the Pathogenesis of Spondyloarthritis., Biomolecules, 10, DOI: 10.3390/biom10101461 251 10.3390/biom10101461 false true Reference 36484973 /api/reference/36484973 252. Sharma 2020: Prescription opioids induce gut dysbiosis and exacerbate colitis in a murine model of inflammatory Bowel Disease., Journal of Crohn's & Colitis, 14, p. 801, DOI: 10.1093/ecco-jcc/jjz188 252 10.1093/ecco-jcc/jjz188 false true Reference 36484974 /api/reference/36484974 253. Shield 1993: Anti-inflammatory drugs and their effects on cartilage synthesis and renal function., European Journal of Rheumatology and Inflammation, 13, p. 7 253 false true Reference 36484975 /api/reference/36484975 254. Shinebaum 1987: Comparison of faecal florae in patients with rheumatoid arthritis and controls., British Journal of Rheumatology, 26, p. 329, DOI: 10.1093/rheumatology/26.5.329 254 10.1093/rheumatology/26.5.329 false true Reference 36484976 /api/reference/36484976 255. Shirin 2006: Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori., Journal of Gastroenterology and Hepatology, 21, p. 1388 255 false true Reference 36484977 /api/reference/36484977 256. Sieper 2009: The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis., Annals of the Rheumatic Diseases, 68, p. ii1-44, DOI: 10.1136/ard.2008.104018 256 10.1136/ard.2008.104018 false true Reference 36484978 /api/reference/36484978 257. Sima 1978: The perineurial and blood-nerve barriers in experimental diabetes., Acta Neuropathologica, 44, p. 189, DOI: 10.1007/BF00691066 257 10.1007/BF00691066 false true Reference 36484979 /api/reference/36484979 258. Simelyte 2003: Role of peptidoglycan subtypes in the pathogenesis of bacterial cell wall arthritis., Annals of the Rheumatic Diseases, 62, p. 976, DOI: 10.1136/ard.62.10.976 258 10.1136/ard.62.10.976 false true Reference 36484980 /api/reference/36484980 259. Simpson 2020: Depletion of the microbiome alters the recruitment of neuronal ensembles of oxycodone intoxication and withdrawal., eNeuro, p. 7 259 false true Reference 36484981 /api/reference/36484981 260. Sindberg 2019: Morphine potentiates dysbiotic microbial and metabolic shifts in acute SIV infection., Journal of Neuroimmune Pharmacology, 14, p. 200, DOI: 10.1007/s11481-018-9805-6 260 10.1007/s11481-018-9805-6 false true Reference 36484982 /api/reference/36484982 261. Singh 2016: A novel model for NSAID induced gastroenteropathy in rats., Journal of Pharmacological and Toxicological Methods, 78, p. 66, DOI: 10.1016/j.vascn.2015.11.008 261 10.1016/j.vascn.2015.11.008 false true Reference 36484983 /api/reference/36484983 262. Singh 2017: Overcoming the exacerbating effects of ranitidine on NSAID-induced small intestinal toxicity with quercetin: Providing a complete GI solution., Chemico-Biological Interactions, 272, p. 53, DOI: 10.1016/j.cbi.2017.04.006 262 10.1016/j.cbi.2017.04.006 false true Reference 36484984 /api/reference/36484984 263. Singh 2000: Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System., American Journal of Therapeutics, 7, p. 115, DOI: 10.1097/00045391-200007020-00008 263 10.1097/00045391-200007020-00008 false true Reference 36484985 /api/reference/36484985 264. Smecuol 2001: Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs., Gut, 49, p. 650, DOI: 10.1136/gut.49.5.650 264 10.1136/gut.49.5.650 false true Reference 36484986 /api/reference/36484986 265. Smits 2013: Therapeutic potential of fecal microbiota transplantation., Gastroenterology, 145, p. 946, DOI: 10.1053/j.gastro.2013.08.058 265 10.1053/j.gastro.2013.08.058 false true Reference 36484987 /api/reference/36484987 266. Smolen 2020: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update., Annals of the Rheumatic Diseases, 79, p. 685, DOI: 10.1136/annrheumdis-2019-216655 266 10.1136/annrheumdis-2019-216655 false true Reference 36484988 /api/reference/36484988 267. Sokol 2008: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients., Proceedings of the National Academy of Sciences of the United States of America, 105, p. 16731, DOI: 10.1073/pnas.0804812105 267 10.1073/pnas.0804812105 false true Reference 36484989 /api/reference/36484989 268. Stebbings 2002: Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis., Rheumatology (Oxford), 41, p. 1395, DOI: 10.1093/rheumatology/41.12.1395 268 10.1093/rheumatology/41.12.1395 false true Reference 36484990 /api/reference/36484990 269. Stecher 2015: The roles of inflammation, nutrient availability and the commensal microbiota in enteric pathogen infection., Microbiology Spectrum, p. 3 269 false true Reference 36484991 /api/reference/36484991 270. Stoll 2014: Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis., Arthritis Research & Therapy, 16, p. 486, DOI: 10.1186/s13075-014-0486-0 270 10.1186/s13075-014-0486-0 false true Reference 36484992 /api/reference/36484992 271. Stoll 2018: Age and fecal microbial strain-specific differences in patients with spondyloarthritis., Arthritis Research & Therapy, 20, p. 14, DOI: 10.1186/s13075-018-1510-6 271 10.1186/s13075-018-1510-6 false true Reference 36484993 /api/reference/36484993 272. Sun 2019: Characteristics of gut microbiota in patients with rheumatoid arthritis in Shanghai, China., Frontiers in Cellular and Infection Microbiology, 9, p. 369, DOI: 10.3389/fcimb.2019.00369 272 10.3389/fcimb.2019.00369 false true Reference 36484994 /api/reference/36484994 273. Sung 1993: Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids., Digestive Diseases and Sciences, 38, p. 2104, DOI: 10.1007/BF01297092 273 10.1007/BF01297092 false true Reference 36484995 /api/reference/36484995 274. Syer 2015: NSAID enteropathy and bacteria: a complicated relationship., Journal of Gastroenterology, 50, p. 387, DOI: 10.1007/s00535-014-1032-1 274 10.1007/s00535-014-1032-1 false true Reference 36484996 /api/reference/36484996 275. Takeuchi 2002: Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats., Digestion, 66, p. 30, DOI: 10.1159/000064419 275 10.1159/000064419 false true Reference 36484997 /api/reference/36484997 276. Talley 1993: Functional constipation and outlet delay: A population-based study., Gastroenterology, 105, p. 781, DOI: 10.1016/0016-5085(93)90896-K 276 10.1016/0016-5085(93)90896-K false true Reference 36484998 /api/reference/36484998 277. Tamanai-Shacoori 2007: The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia., Anesthesia and Analgesia, 105, p. 524, DOI: 10.1213/01.ane.0000267525.51017.b8 277 10.1213/01.ane.0000267525.51017.b8 false true Reference 36484999 /api/reference/36484999 278. Tan 2021: Intestinal microbiota mediates high-fructose and high-fat diets to induce chronic intestinal inflammation., Frontiers in Cellular and Infection Microbiology, 11, DOI: 10.3389/fcimb.2021.654074 278 10.3389/fcimb.2021.654074 false true Reference 36485000 /api/reference/36485000 279. Tanaka 2002: Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events., The Journal of Pharmacology and Experimental Therapeutics, 303, p. 1248, DOI: 10.1124/jpet.102.041715 279 10.1124/jpet.102.041715 false true Reference 36485001 /api/reference/36485001 280. Taurog 1994: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats., The Journal of Experimental Medicine, 180, p. 2359, DOI: 10.1084/jem.180.6.2359 280 10.1084/jem.180.6.2359 false true Reference 36485002 /api/reference/36485002 281. Teran-Ventura 2014: Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats., Journal of Crohn's & Colitis, 8, p. 1043, DOI: 10.1016/j.crohns.2014.02.001 281 10.1016/j.crohns.2014.02.001 false true Reference 36485003 /api/reference/36485003 282. Thangamani 2015: Repurposing celecoxib as a topical antimicrobial agent., Frontiers in Microbiology, 6, p. 750, DOI: 10.3389/fmicb.2015.00750 282 10.3389/fmicb.2015.00750 false true Reference 36485004 /api/reference/36485004 283. Thompson 2001: Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis., The American Journal of Gastroenterology, 96, p. 1266, DOI: 10.1111/j.1572-0241.2001.03536.x 283 10.1111/j.1572-0241.2001.03536.x false true Reference 36485005 /api/reference/36485005 284. Tito 2017: Brief report: Dialister as a microbial marker of disease activity in spondyloarthritis., Arthritis & Rhematology, 69, p. 114, DOI: 10.1002/art.39802 284 10.1002/art.39802 false true Reference 36485006 /api/reference/36485006 285. Tolhurst 2012: Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2., Diabetes, 61, p. 364, DOI: 10.2337/db11-1019 285 10.2337/db11-1019 false true Reference 36485007 /api/reference/36485007 286. Touw 2017: Mutual reinforcement of pathophysiological host-microbe interactions in intestinal stasis models., Physiological Reports, 5, DOI: 10.14814/phy2.13182 286 10.14814/phy2.13182 false true Reference 36485008 /api/reference/36485008 287. Uchida 1997: Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation., The American Journal of Physiology, 272, p. G1249 287 false true Reference 36485009 /api/reference/36485009 288. Uejima 1996: Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug., Microbiology and Immunology, 40, p. 553, DOI: 10.1111/j.1348-0421.1996.tb01108.x 288 10.1111/j.1348-0421.1996.tb01108.x false true Reference 36485010 /api/reference/36485010 289. Vaahtovuo 2008: Fecal microbiota in early rheumatoid arthritis., The Journal of Rheumatology, 35, p. 1500 289 false true Reference 36485011 /api/reference/36485011 290. Vadstein 2018: K-selection as microbial community management strategy: A method for improved viability of larvae in aquaculture., Frontiers in Microbiology, 9, p. 2730, DOI: 10.3389/fmicb.2018.02730 290 10.3389/fmicb.2018.02730 false true Reference 36485012 /api/reference/36485012 291. Vaghef-Mehrabany 2014: Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis., Nutrition, 30, p. 430, DOI: 10.1016/j.nut.2013.09.007 291 10.1016/j.nut.2013.09.007 false true Reference 36485013 /api/reference/36485013 292. Valdes 2018: Role of the gut microbiota in nutrition and health., Bmj, 361 292 false true Reference 36485014 /api/reference/36485014 293. Valladares 2010: Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats., PLoS One, 5, DOI: 10.1371/journal.pone.0010507 293 10.1371/journal.pone.0010507 false true Reference 36485015 /api/reference/36485015 294. Van Praet 2013: Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model., Annals of the Rheumatic Diseases, 72, p. 414, DOI: 10.1136/annrheumdis-2012-202135 294 10.1136/annrheumdis-2012-202135 false true Reference 36485016 /api/reference/36485016 295. Vane 1971: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs., Nature: New Biology, 231, p. 232 295 false true Reference 36485017 /api/reference/36485017 296. Verdú 2006: Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice., Gut, 55, p. 182, DOI: 10.1136/gut.2005.066100 296 10.1136/gut.2005.066100 false true Reference 36485018 /api/reference/36485018 297. Vich Vila 2020: Impact of commonly used drugs on the composition and metabolic function of the gut microbiota., Nature Communications, 11, p. 362, DOI: 10.1038/s41467-019-14177-z 297 10.1038/s41467-019-14177-z false true Reference 36485019 /api/reference/36485019 298. Wallace 2000: NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2., Gastroenterology, 119, p. 706, DOI: 10.1053/gast.2000.16510 298 10.1053/gast.2000.16510 false true Reference 36485020 /api/reference/36485020 299. Wang 2018: Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model., Scientific Reports, 8, p. 3596, DOI: 10.1038/s41598-018-21915-8 299 10.1038/s41598-018-21915-8 false true Reference 36485021 /api/reference/36485021 300. Wang 2017: Gut homeostasis, microbial dysbiosis, and opioids., Toxicologic Pathology, 45, p. 150, DOI: 10.1177/0192623316679898 300 10.1177/0192623316679898 false true Reference 36485022 /api/reference/36485022 301. Wang 2020: Promising treatment for Type 2 Diabetes: Fecal microbiota transplantation reverses insulin resistance and impaired islets., Frontiers in Cellular and Infection Microbiology, 9, p. 455, DOI: 10.3389/fcimb.2019.00455 301 10.3389/fcimb.2019.00455 false true Reference 36485023 /api/reference/36485023 302. Wang 2022: Transdermal administration of volatile oil from citrus aurantium-rhizoma atractylodis macrocephalae alleviates constipation in rats by altering host metabolome and intestinal microbiota composition., Oxidative Medicine and Cellular Longevity, 2022, p. 9965334 302 false true Reference 36485024 /api/reference/36485024 303. Wang 2022: Gut microbiota changes in patients with spondyloarthritis: A systematic review., Seminars in Arthritis and Rheumatism, 52, DOI: 10.1016/j.semarthrit.2021.11.002 303 10.1016/j.semarthrit.2021.11.002 false true Reference 36485025 /api/reference/36485025 304. Wang 2017: Multiple effects of probiotics on different types of diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials., Journal of Pediatric Endocrinology & Metabolism, 30, p. 611, DOI: 10.1515/jpem-2016-0230 304 10.1515/jpem-2016-0230 false true Reference 36485026 /api/reference/36485026 305. Wang 2020: Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes., The Journal of International Medical Research, 48 305 false true Reference 36485027 /api/reference/36485027 306. Watanabe 2009: Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid., American Journal of Physiology. Gastrointestinal and Liver Physiology, 297, p. G506, DOI: 10.1152/ajpgi.90553.2008 306 10.1152/ajpgi.90553.2008 false true Reference 36485028 /api/reference/36485028 307. Wen 2017: Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis., Genome Biology, 18, p. 142, DOI: 10.1186/s13059-017-1271-6 307 10.1186/s13059-017-1271-6 false true Reference 36485029 /api/reference/36485029 308. Whitfield-Cargile 2018: Differential effects of selective and non-selective cyclooxygenase inhibitors on fecal microbiota in adult horses., PLoS One, 13, DOI: 10.1371/journal.pone.0202527 308 10.1371/journal.pone.0202527 false true Reference 36485030 /api/reference/36485030 309. Whitfield-Cargile 2021: Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses., Journal of Veterinary Internal Medicine, 35, p. 1121, DOI: 10.1111/jvim.16093 309 10.1111/jvim.16093 false true Reference 36485031 /api/reference/36485031 310. Winter 2013: The dynamics of gut-associated microbial communities during inflammation., EMBO Reports, 14, p. 319, DOI: 10.1038/embor.2013.27 310 10.1038/embor.2013.27 false true Reference 36485032 /api/reference/36485032 311. Winter 2010: Gut inflammation provides a respiratory electron acceptor for Salmonella., Nature, 467, p. 426, DOI: 10.1038/nature09415 311 10.1038/nature09415 false true Reference 36485033 /api/reference/36485033 312. Winter 2013: Host-derived nitrate boosts growth of E. coli in the inflamed gut., Science, 339, p. 708, DOI: 10.1126/science.1232467 312 10.1126/science.1232467 false true Reference 36485034 /api/reference/36485034 313. Wu 2011: Linking long-term dietary patterns with gut microbial enterotypes., Science, 334, p. 105, DOI: 10.1126/science.1208344 313 10.1126/science.1208344 false true Reference 36485035 /api/reference/36485035 314. Wu 2020: The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study., Cell Metabolism, 32, p. 379, DOI: 10.1016/j.cmet.2020.06.011 314 10.1016/j.cmet.2020.06.011 false true Reference 36485036 /api/reference/36485036 315. Wu 2010: Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells., Immunity, 32, p. 815, DOI: 10.1016/j.immuni.2010.06.001 315 10.1016/j.immuni.2010.06.001 false true Reference 36485037 /api/reference/36485037 316. Xiao 2017: Gut microbiota mediates protection against enteropathy induced by indomethacin., Scientific Reports, 7, p. 40317, DOI: 10.1038/srep40317 316 10.1038/srep40317 false true Reference 36485038 /api/reference/36485038 317. Xie 2020: Jinmaitong ameliorates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats by modulating gut microbiota and neuregulin 1., Aging (Albany NY), 12, p. 17436, DOI: 10.18632/aging.103750 317 10.18632/aging.103750 false true Reference 36485039 /api/reference/36485039 318. Xie 2020: Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level., Biomedicine & Pharmacotherapy, 127, DOI: 10.1016/j.biopha.2020.110147 318 10.1016/j.biopha.2020.110147 false true Reference 36485040 /api/reference/36485040 319. Yamada 1993: Mechanisms of acute and chronic intestinal inflammation induced by indomethacin., Inflammation, 17, p. 641, DOI: 10.1007/BF00920471 319 10.1007/BF00920471 false true Reference 36485041 /api/reference/36485041 320. Yamada 1996: Bile secretion in rats with indomethacin-induced intestinal inflammation., The American Journal of Physiology, 270, p. G804 320 false true Reference 36485042 /api/reference/36485042 321. Yan 2020: Chlorogenic acid protects against indomethacin-induced inflammation and mucosa damage by decreasing bacteroides-derived LPS., Frontiers in Immunology, 11, p. 1125, DOI: 10.3389/fimmu.2020.01125 321 10.3389/fimmu.2020.01125 false true Reference 36485043 /api/reference/36485043 322. Yin 2020: Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition., Annals of the Rheumatic Diseases, 79, p. 132, DOI: 10.1136/annrheumdis-2019-215763 322 10.1136/annrheumdis-2019-215763 false true Reference 36485044 /api/reference/36485044 323. Yin 2014: DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs., Chemistry & Biology, 21, p. 481, DOI: 10.1016/j.chembiol.2014.02.009 323 10.1016/j.chembiol.2014.02.009 false true Reference 36485045 /api/reference/36485045 324. Yokota 2005: Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats., The Journal of Pharmacology and Experimental Therapeutics, 314, p. 302, DOI: 10.1124/jpet.105.084962 324 10.1124/jpet.105.084962 false true Reference 36485046 /api/reference/36485046 325. Young 1993: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population., Diabetologia, 36, p. 150, DOI: 10.1007/BF00400697 325 10.1007/BF00400697 false true Reference 36485047 /api/reference/36485047 326. Zaragoza-Garcia 2020: DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy., Biomolecules, 10, DOI: 10.3390/biom10111479 326 10.3390/biom10111479 false true Reference 36485048 /api/reference/36485048 327. Zeng 2021: Fecal microbiota transplantation for rheumatoid arthritis: A case report., Clinical Case Reports, 9, p. 906, DOI: 10.1002/ccr3.3677 327 10.1002/ccr3.3677 false true Reference 36485049 /api/reference/36485049 328. Zeng 2017: Mechanisms of inflammation-driven bacterial dysbiosis in the gut., Mucosal Immunology, 10, p. 18, DOI: 10.1038/mi.2016.75 328 10.1038/mi.2016.75 false true Reference 36485050 /api/reference/36485050 329. Zhang 2021: Differential alteration in gut microbiome profiles during acquisition, extinction and reinstatement of morphine-induced CPP., Progress in Neuro-Psychopharmacology & Biological Psychiatry, 104, DOI: 10.1016/j.pnpbp.2020.110058 329 10.1016/j.pnpbp.2020.110058 false true Reference 36485051 /api/reference/36485051 330. Zhang 2020: Sensitivity to morphine reward associates with gut dysbiosis in rats with morphine-induced conditioned place preference., Frontiers in Psychiatry, 11, p. 631, DOI: 10.3389/fpsyt.2020.00631 330 10.3389/fpsyt.2020.00631 false true Reference 36485052 /api/reference/36485052 331. Zhang 2019: Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity., Clinica Chimica Acta, 497, p. 189, DOI: 10.1016/j.cca.2019.07.038 331 10.1016/j.cca.2019.07.038 false true Reference 36485053 /api/reference/36485053 332. Zhang 2019: Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome., Proceedings of the National Academy of Sciences of the United States of America, 116, p. 13523, DOI: 10.1073/pnas.1901182116 332 10.1073/pnas.1901182116 false true Reference 36485054 /api/reference/36485054 333. Zhang 2018: Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: A retrospective cohort study using electronic health records., PLoS One, 13 333 false true Reference 36485055 /api/reference/36485055 334. Zhang 2015: The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment., Nature Medicine, 21, p. 895, DOI: 10.1038/nm.3914 334 10.1038/nm.3914 false true Reference 36485056 /api/reference/36485056 335. Zhao 2020: Aspirin reduces colorectal tumor development in mice and gut microbes reduce its bioavailability and chemopreventive effects., Gastroenterology, 159 335 false true Reference 36485057 /api/reference/36485057 336. Zhou 2020: Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis., Journal of Autoimmunity, 107, DOI: 10.1016/j.jaut.2019.102360 336 10.1016/j.jaut.2019.102360 false true Reference 36485058 /api/reference/36485058 337. Zhou 2016: Lower level of bacteroides in the gut microbiota is associated with inflammatory bowel disease: a meta-analysis., BioMed Research International, 2016, p. 5828959, DOI: 10.1155/2016/5828959 337 10.1155/2016/5828959 false true Reference 36485059 /api/reference/36485059 338. Zimmermann 2017: Antimicrobial effects of antipyretics., Antimicrobial Agents and Chemotherapy, 61, DOI: 10.1128/AAC.02268-16 338 10.1128/AAC.02268-16 false true /api/publication/33298915 Zádori Zoltán S. et al. Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain. (2023) PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X 241<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10017488"><a href="/gui2/?type=authors&mode=browse&sel=10017488" target="_blank">Zádori Zoltán S. ✉ (<span class="authorship-author-name">Zádori Zoltán Sándor</span> <span class="authorAux-mtmt"> Farmakológia, gasztrointesztinális farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10015480"><a href="/gui2/?type=authors&mode=browse&sel=10015480" target="_blank">Király Kornél (<span class="authorship-author-name">Király Kornél P</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10015484"><a href="/gui2/?type=authors&mode=browse&sel=10015484" target="_blank">Al-Khrasani Mahmoud (<span class="authorship-author-name">Al-Khrasani Mahmoud</span> <span class="authorAux-mtmt"> Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10007320"><a href="/gui2/?type=authors&mode=browse&sel=10007320" target="_blank">Gyires Klára (<span class="authorship-author-name">Gyires Klára</span> <span class="authorAux-mtmt"> Farmakológia, gasztrointesztinális farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;33298915" target="_blank">Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain</a></div> <div> <span class="journal-title">PHARMACOLOGY & THERAPEUTICS</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0163-7258">0163-7258</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1879-016X">1879-016X</a>)</span>: <span class="journal-volume">241</span> <span class="page"> Paper 108327. 29 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.pharmthera.2022.108327" target="_blank" href="https://doi.org/10.1016/j.pharmthera.2022.108327"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000906912700005" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000906912700005"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85143829907" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85143829907"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="36473615" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36473615&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pharmacology (medical)&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 89</span> | Független: 87 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 71 | Scopus jelölt:&nbsp;60 | WoS/Scopus jelölt:&nbsp;71 | DOI jelölt:&nbsp;77 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;33298915&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 10 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 33298915</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Összefoglaló cikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (FK 138842), (TKP2021-EGA-25) </div> <div class="lastModified">Utolsó módosítás: 2022.12.20. 11:53 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Export Date: 4 January 2023 CODEN: PHTHD Correspondence Address: Zádori, Z.S.; Department of Pharmacology and Pharmacotherapy, Nagyvárad tér 4., Hungary; email: zadori.zoltan@med.semmelweis-univ.hu</pre> </div></div>